Online tool encourages families to bone up on genetics

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 12
Volume 17
Issue 12

Ohio State University’s Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute have developed a free, online assessment tool that allows individuals to enter their family medical history, and determine their risk for both cancer and coronary heart disease.

Ohio State University’s Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute have developed a free, online assessment tool that allows individuals to enter their family medical history, and determine their risk for both cancer and coronary heart disease.

Called Family HealthLink, the tool was created by the Clinical Cancer Genetics and Medical Genetics Programs. The survey takes approximately 15 minutes to complete and provides a printable risk assessment that can be used for discussion with a physician or genetic counselor.

“It is important that families take the time to discuss their health in order to better understand their risk for cancer and coronary heart disease and improve screening and prevention methods,” said Kevin Sweet, genetic counselor and director of the Family HealthLink project.

To access Family HealthLink, go to familyhealthlink.osumc.edu or call 1-888-329-1654 to reach the genetics programs by phone.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content